NANDROTEX D250 - Nandrolone Decanoate

Key Benefits of NANDROTEX D250: Sustained muscle growth: The prolonged release of the decanoate ester allows for stable anabolic blood levels for 3-4 weeks with a single injection . This favors constant and quality muscle growth without sudden hormonal peaks. Documented muscle mass gains: A clinical study in bodybuilders demonstrated that administration of 200 mg/week of nandrolone for 8 weeks resulted in significant increases of +2.2 kg body mass and +2.6 kg fat-free mass, with no changes in body fat . Significant strength increase: Users experience notable improvements in strength in compound exercises, allowing for training progression and muscle growth stimulation. Accelerated recovery: Promotes protein synthesis, improves nitrogen balance, and reduces recovery time between training sessions, allowing for greater training frequency and intensity . Appetite stimulation: Known for its ability to stimulate appetite, facilitating the caloric surplus necessary for muscle growth during bulking phases. Joint health: Promotes synovial fluid retention, improving joint lubrication and reducing joint pain during high-intensity training . Prolonged release (depot action): With an absorption half-life of 6-7 days and a peak concentration time that can reach 72 hours at higher doses , nandrolone offers an extended therapeutic window that reduces injection frequency. High concentration 250 mg/mL: The maximum concentration presentation allows for effective doses with less injection volume, reducing tissue trauma and improving cycle comfort. Versatility: Effective in both bulking and body recomposition cycles, adapting to the needs of different athletes.

How does NANDROTEX D250 work? Nandrotex D250 contains Nandrolone Decanoate USP, an anabolic-androgenic steroid derived from 19-nortestosterone with a unique structure that gives it exceptional properties for muscle growth : Protein synthesis: Increases protein synthesis in muscle tissue through androgen receptor activation and the mTOR pathway, promoting muscle growth and repair . Nitrogen balance: Improves nitrogen balance, creating an anabolic state favorable for muscle maintenance and development . Low aromatization: Nandrolone aromatizes to estrogen at approximately 20% of the rate of testosterone , resulting in less water retention and lower risk of estrogenic effects compared to testosterone. Progestational activity: Activates the progesterone receptor, which may contribute to its HPG axis suppressive effect and its fluid retention properties. SHBG reduction: Decreases sex hormone binding globulin levels, increasing the free fraction of testosterone and other anabolic compounds. Anticatabolic effect: Acts as a potent anticatabolic agent, preserving muscle tissue during caloric deficit and metabolic stress states. Erythropoiesis: Stimulates red blood cell production, improving oxygen transport and physical performance. Prolonged-release pharmacokinetics: The decanoate ester is slowly released from the injection site with a half-life of 6 days . In blood, the ester is rapidly hydrolyzed to nandrolone with a half-life of one hour or less. The half-life for the combined process of hydrolysis of nandrolone decanoate and distribution and elimination of nandrolone is 4.3 hours . Peak serum concentrations are reached between 30 and 72 hours after injection, depending on the dose . Metabolism: Nandrolone is metabolized in the liver and excreted in urine as 19-norandrosterone, 19-noretiocholanolone, and 19-norepiandrosterone

Usage Guide for NANDROTEX D250: Administration route: Deep and slow intramuscular injection, preferably in the glute (upper outer quadrant) or deltoid. Should not be administered intravenously . Frequency: Due to its prolonged-release action with a half-life of 6-7 days , administration is recommended every 7-10 days to maintain stable plasma levels. Recommended dosage for men: 200 to 400 mg every 7-10 days (0.8 to 1.6 mL of NANDROTEX D250). Bulking protocols typically last 8 to 16 weeks. A clinical study documented significant gains with doses of 200 mg/week for 8 weeks . Recommended dosage for women: Not recommended for use in women due to high risk of virilization (voice deepening, facial hair growth, etc.). Nandrolone, like other anabolic steroids, can produce virilizing effects in women . Recommended cycle: Ideal for bulking protocols and sustained muscle development. Excellent for 8-16 week cycles. Stacking: Frequently combined with testosterone (as a base) to maintain adequate androgen levels, and with oral compounds such as Dianabol or Anadrol to enhance bulking effects in the initial phase of the cycle. Post-cycle therapy (PCT): PCT should be started approximately 3 weeks after the last injection due to the compound's prolonged release. Typical 4-week protocol with Clomiphene (50 mg/day) or Tamoxifen (20 mg/day). In cases of severe suppression, HCG may be necessary. Precautions and monitoring: Periodic monitoring of liver function, lipid profile, and hemoglobin is recommended during the cycle . Nandrolone may improve glucose tolerance in diabetic patients , so blood sugar levels should be monitored. Anti-doping warning: Nandrolone is included in the WADA 2025-2026 Prohibited List as S1.1 Anabolic Androgenic Steroids, prohibited at all times (in and out of competition) . Nandrolone metabolites can be detected in urine for up to 6 months after administration

Composition of NANDROTEX D250: Active Ingredient: Nandrolone Decanoate USP 250 mg per mL. High-purity compound with USP pharmaceutical grade . Chemical name: 17β-hydroxy-19-nor-4-androsten-3-one decanoate . Molecular formula: C₂₈H₄₄O₃ . Vehicle: Pharmaceutical-grade arachis oil (peanut oil), selected for its low viscosity and excellent tolerance profile . Preservative: Benzyl alcohol (approximately 10% v/v), ensuring product stability and sterility . Presentation: 10 mL multi-dose vial with 250 mg/mL concentration. Total of 2500 mg of Nandrolone Decanoate per vial (10 doses of 1 mL for 250 mg doses) . Appearance: Clear yellow oily solution . Certification: Manufactured under USP (United States Pharmacopeia) and GMP (Good Manufacturing Practices) standards . Quality control: Purity and potency testing performed by certified independent laboratories using high-performance liquid chromatography (HPLC) and mass spectrometry. Purity: >98% purity, guaranteeing maximum quality and consistency in each batch. Storage: Store at controlled room temperature 20°-25°C (68°-77°F), in a dry place protected from light. Do not freeze . Do not use if foreign particles are observe

Onset time and expected results: Onset time: Anabolic effects begin to be noticeable between 7 and 14 days of continuous use. Peak blood concentration is reached between 30 and 72 hours after injection . Results at 2-4 weeks: Increased strength, improved recovery, appetite stimulation, and general sense of well-being. Initial body weight gain due to fluid retention. Results at 4-6 weeks: Significant improvement in body composition, lean muscle mass gain, and body fat reduction. Users report gains of +2.2 kg body mass and +2.6 kg fat-free mass in 8 weeks . Results at 6-8 weeks: Notable muscle growth, sustained strength increase, and improved recovery. Muscle gains continue progressively. Results at 8-12 weeks: Optimal results with quality muscle mass gains, increased strength, and superior recovery. Expected results (8-12 week cycle at 200-400 mg/week): Lean muscle mass: +2.6 kg (documented in clinical study at 200 mg/week) Total body mass: +2.2 kg Strength increase in compound exercises: +10-20% Body fat reduction: Maintenance or slight reduction Water retention: Moderate (less than testosterone) Recovery: Significantly accelerated

Clinical research and laboratory testing: Clinical studies on muscle gains: A randomized, double-blind, placebo-controlled study in 16 male bodybuilders demonstrated that administration of 200 mg/week of nandrolone decanoate for 8 weeks resulted in significant increases in body mass (+2.2 kg) and fat-free mass (+2.6 kg), with no changes in body fat, bone mineral content, or bone mineral density . 2026 Meta-analysis: A systematic review and meta-analysis published in 2026 evaluated the effect of nandrolone decanoate on lean soft tissue, fat mass, handgrip strength, knee extension strength, and bone mineral density in adults. Results suggest that AAS administration in cachectic and sarcopenic conditions may be a viable interventional strategy to enhance muscle function, and combining AAS with exercise may enhance positive outcomes . Medical applications: Nandrolone is used in the treatment of osteoporosis in postmenopausal women, certain types of anemia, and breast cancer (in women) . It has been shown to increase bone mineral density, muscle mass, and hemoglobin levels in elderly women with osteoporosis . Documented pharmacokinetics: The pharmacokinetic profiles of nandrolone have been extensively studied. Peak serum concentrations are reached between 30 and 72 hours after injection, and the terminal half-life is 7-12 days . Metabolite detection: Nandrolone metabolites (19-norandrosterone and 19-noretiocholanolone) can be detected in urine for extended periods. In studies with 150 mg doses, metabolites could be detected up to 6 months after administration in 67-83% of subjects . Safety profile: Abuse of anabolic-androgenic steroids such as nandrolone can lead to serious health risks, including cardiovascular (with fatal outcomes in some cases), hepatic, and/or psychiatric events . Nandrolone may improve glucose tolerance in diabetic patients . Liver function monitoring is recommended in patients with severe hepatic impairment . 3rd party testing: Our batches are subjected to purity and potency testing by certified independent laboratories using: High-performance liquid chromatography (HPLC) for purity Mass spectrometry for molecular identification Sterility and bacterial endotoxin testing Certifications: Manufactured under GMP (Good Manufacturing Practices) standards USP quality control (United States Pharmacopeia) Stability and shelf-life testing (24 months) Heavy metals and contaminant analysis Anti-doping warning: Nandrolone is included in the WADA 2025-2026 Prohibited List as S1.1 Anabolic Androgenic Steroids, prohibited at all times (in and out of competition) . Nandrolone metabolites can be detected in urine for extended periods, making it one of the substances with the longest detection window